Publications by authors named "Christian M Hackeng"

Claim this Profile
D
Does Intraoperative Fibrinogen Affect Blood Loss or Transfusion Practice After Aortic Arch Surgery: A Prematurely Ended Randomized Trial.
Eline A Vlot, Christian M Hackeng, Stijn J A Aper, Uday Sonker, Robin H Heijmen

Clin Appl Thromb Hemost· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing.
Laura M Willemsen, Eline A Vlot, Paul W A Janssen, Claire D Visser, Kai Zheng, Christian M Hackeng

Res Pract Thromb Haemost· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Plasma Fibrinogen and Thromboelastography With Blood Loss in Complex Cardiac Surgery.
Eline A Vlot, Eric P A van Dongen, Laura M Willemsen, Jur M Ten Berg, Christian M Hackeng

Clin Appl Thromb Hemost· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of *22 and Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention.
Thomas O Bergmeijer, Alfi Yasmina, Gerrit J A Vos, Paul W A Janssen, Christian M Hackeng

Genes (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative point of care platelet function testing and postoperative blood loss in high-risk cardiac surgery patients.
Eline A Vlot, Laura M Willemsen, Eric P A Van Dongen, Paul W Janssen, Christian M Hackeng

Platelets· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored P2Y inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study.
Paul W A Janssen, Thomas O Bergmeijer, Gert-Jan A Vos, Johannes C Kelder, Khalid Qaderdan, Christian M Hackeng

Eur J Clin Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS).
Thomas O Bergmeijer, Thea C Godschalk, Paul W A Janssen, Kim van den Berge, Nicoline J Breet, Christian M Hackeng

Semin Thromb Hemost· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Tailored Antiplatelet Therapy to Reduce Recurrent Stent Thrombosis and Cardiac Death After a First Episode of Stent Thrombosis.
Thea C Godschalk, Laura M Willemsen, Bastiaan Zwart, Thomas O Bergmeijer, Paul Willem A Janssen, Christian M Hackeng

Am J Cardiol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Point-of-Care Platelet Function Testing Using Multiple Electrode Aggregometry in Patients Undergoing Cardiac Surgery.
Eline A Vlot, Nanda Meents, Ewoudt M W van de Garde, Christian M Hackeng, Peter G Noordzij

J Cardiothorac Vasc Anesth· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
Thea C Godschalk, Joke Konings, José W Govers-Riemslag, Jurriën M Ten Berg, Christian M Hackeng

Thromb Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of acenocoumarol on the antiplatelet effect of clopidogrel.
Willem J M Dewilde, Paul W A Janssen, Thomas O Bergmeijer, Johannes C Kelder, Christian M Hackeng

Thromb Haemost· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint.
Jeroen Diepstraten, Esther J H Janssen, Christian M Hackeng, Eric P A van Dongen, René J Wiezer

Eur J Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of platelet function testing in PCI and CABG patients.
Paul W A Janssen, Jurriën M ten Berg, Christian M Hackeng

Blood Rev· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards personalized medicine based on platelet function testing for stent thrombosis patients.
Thea Cornelia Godschalk, Christian Marcus Hackeng, Jurriën Maria Ten Berg

Thrombosis· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stenting.
Ankie M Harmsze, Jochem W van Werkum, Christian M Hackeng, Hendrik J T Ruven, Johannes C Kelder

Pharmacogenet Genomics· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.
Jeroen Diepstraten, Christian M Hackeng, Simone van Kralingen, Jiri Zapletal, Eric P A van Dongen

Obes Surg· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.
Heleen J Bouman, Jochem W van Werkum, Goran Rudež, Christian M Hackeng, Frank W G Leebeek

Thromb Haemost· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting.
Heleen J Bouman, Ankie M Harmsze, Jochem W van Werkum, Nicoline J Breet, Th O Bergmeijer, Christian M Hackeng

Heart· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction.
Nicoline J Breet, Jochem W van Werkum, Heleen J Bouman, Johannes C Kelder, Christian M Hackeng

Thromb Haemost· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
Nicoline J Breet, Jochem W van Werkum, Heleen J Bouman, Johannes C Kelder, Ankie M Harmsze, Christian M Hackeng

Heart· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients.
Ankie M Harmsze, Jochem W Van Werkum, Fulya Moral, Jurri N M Ten Berg, Christian M Hackeng

Platelets· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esomeprazole but not pantoprazole is associated with lower plasma concentrations of clopidogrel's active metabolite.
Ankie M Harmsze, Jochem W van Werkum, Dirk Taubert, Christian M Hackeng, Vera H M Deneer

Ann Pharmacother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both peak and late aggregation are capable of identifying patients at risk for atherothrombotic events.
Nicoline J Breet, Jochem W van Werkum, Heleen J Bouman, Johannes C Kelder, Jurriën M Ten Berg, Christian M Hackeng

Thromb Haemost· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraoxonase-1 is a major determinant of clopidogrel efficacy.
Heleen J Bouman, Edgar Schömig, Jochem W van Werkum, Janna Velder, Christian M Hackeng

Nat Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.
Ankie M Harmsze, Jochem W van Werkum, Jurriën M Ten Berg, Bastiaan Zwart, Heleen J Bouman, Christian M Hackeng

Eur Heart J· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis